ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
HeartSciences Inc

HeartSciences Inc (HSCS)

3,42
-0,34
(-9,04%)
Fermé 20 Décembre 10:00PM
3,84
0,42
( 12,28% )
Avant marché: 10:48AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
3,84
Prix Achat
3,78
Prix Vente
4,04
Volume échangé
524
0,00 Fourchette du Jour 0,00
2,36 Plage de 52 semaines 18,50
Cap du marché
Clôture Veille
3,42
Ouverture
-
Dernière Transaction
97
@
3.82
Dernière heure de transaction
10:46:37
Volume financier
-
VWAP
-
Volume moyen (3 m)
48 084
Actions en circulation
911 321
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,47
Bénéfice par action (BPA)
-7,25
Chiffre d'affairess
19k
Bénéfice net
-6,61M

À propos de HeartSciences Inc

Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-o... Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. Show more

Secteur
Ortho,prosth,surg Appl,suply
Industrie
Ortho,prosth,surg Appl,suply
Siège social
Southlake, Texas, USA
Fondé
-
HeartSciences Inc est coté dans le secteur Ortho,prosth,surg Appl,suply de la NASDAQ avec le ticker HSCS. Le dernier cours de clôture d'HeartSciences était de US$3,42. Au cours de la dernière année, les actions de HeartSciences ont été négociées dans une fourchette de prix de US$ 2,36 à US$ 18,50.

HeartSciences compte actuellement 911 321 actions en circulation. La capitalisation boursière d'HeartSciences est de US$3,12 million. HeartSciences a un ratio cours/bénéfice (ratio PE) de -0.47.

HSCS Dernières nouvelles

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company...

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Southlake, TX, July 29, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Southlake, TX, July 25, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Southlake, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.21-5.185185185194.054.053.321194993.60568056CS
41.2447.69230769232.64.69022.6545843.67281599CS
12-0.78-16.88311688314.625.29892.5164480843.74301006CS
26-1.56-28.88888888895.45.772.362128684.04271986CS
52-12.7-76.783555018116.5418.52.36133753212.35247971CS
156-371.16-98.9763756002.36175134177.23958396CS
260-371.16-98.9763756002.36175134177.23958396CS

HSCS - Frequently Asked Questions (FAQ)

What is the current HeartSciences share price?
The current share price of HeartSciences is US$ 3,84
How many HeartSciences shares are in issue?
HeartSciences has 911 321 shares in issue
What is the market cap of HeartSciences?
The market capitalisation of HeartSciences is USD 3,12M
What is the 1 year trading range for HeartSciences share price?
HeartSciences has traded in the range of US$ 2,36 to US$ 18,50 during the past year
What is the PE ratio of HeartSciences?
The price to earnings ratio of HeartSciences is -0,47
What is the cash to sales ratio of HeartSciences?
The cash to sales ratio of HeartSciences is 164,42
What is the reporting currency for HeartSciences?
HeartSciences reports financial results in USD
What is the latest annual turnover for HeartSciences?
The latest annual turnover of HeartSciences is USD 19k
What is the latest annual profit for HeartSciences?
The latest annual profit of HeartSciences is USD -6,61M
What is the registered address of HeartSciences?
The registered address for HeartSciences is 550 RESERVE ST, SUITE 360, SOUTHLAKE, TEXAS, 76092
What is the HeartSciences website address?
The website address for HeartSciences is www.heartsciences.com
Which industry sector does HeartSciences operate in?
HeartSciences operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
APTOAptose Biosciences Inc
US$ 0,3566
(109,52%)
16,7M
PBMPsyence Biomedical Ltd
US$ 4,75
(93,09%)
5,92M
NVNINVNI Group Ltd
US$ 4,67
(74,91%)
1,78M
ADDColor Star Technology Company Ltd
US$ 3,86
(56,28%)
1,53M
LATGUChenghe Acquisition I Company
US$ 18,94
(56,01%)
100
MTEMMolecular Templates Inc
US$ 0,1682
(-51,94%)
57,76k
PRFXPainReform Ltd
US$ 7,00
(-37,28%)
83,54k
CPIXCumberland Pharmaceutical Inc
US$ 1,64
(-29,31%)
144
XHGXChange TED Inc
US$ 0,921
(-29,15%)
66,19k
CARACara Therapeutics Inc
US$ 0,3023
(-26,07%)
63,77k
APTOAptose Biosciences Inc
US$ 0,3566
(109,52%)
16,7M
PBMPsyence Biomedical Ltd
US$ 4,75
(93,09%)
5,92M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 29,73
(-9,36%)
3,33M
HUMAHumacyte Inc
US$ 5,37
(55,20%)
2,38M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,533
(-6,49%)
2,26M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock